Over 250 New Jersey Auctions End Tomorrow 09/26 - Bid Now
Over 60 Total Lots Up For Auction at One Location - CA 10/05

Lantheus announces new CMO, CCO

by Brendon Nafziger, DOTmed News Associate Editor | September 29, 2011
Cyrille Villeneuve (Credit: Lantheus)
Lantheus Medical Imaging Inc. said Wednesday it promoted Cyrille Villeneuve to chief commercial officer and Dr. Dana Washburn to chief medical officer.

Villeneuve, previously vice president and general manager, international, will now direct the N. Billerica, Mass.-based radiopharmaceutical company's global commercial strategy. Vileneuve has been with Lantheus since 1985, when it was still owned by E.I. du Pont de Nemours and Company, and before its sale to Bristol-Myers Squibb Company and later purchase by Avista Capital Partners.
Dr. Dana Washburn (Credit: Lantheus)

Washburn joined Lantheus last year as vice president, clinical development and medical affairs. Don Kiepert, Lantheus' president and CEO, said he made a big impact on the company's flurpiridaz F-18 radiotracer research, which began phase III clinical trials in June.
DOTmed text ad

New Fully Configured 80-slice CT in 2 weeks with Software Upgrades for Life

For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.

"His deep industry experience and work as a practicing nuclear cardiologist make him ideal for our new position of chief medical officer," Kiepert said in a statement.

You Must Be Logged In To Post A Comment